Abo Bibliothek: Guest
Critical Reviews™ in Oncogenesis

Erscheint 4 Ausgaben pro Jahr

ISSN Druckformat: 0893-9675

ISSN Online: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

The Role of Stem Cell Factor SALL4 in Leukemogenesis

Volumen 16, Ausgabe 1-2, 2011, pp. 117-127
DOI: 10.1615/CritRevOncog.v16.i1-2.110
Get accessGet access

ABSTRAKT

SALL4, a member of the SALL gene family, is one of the most important transcriptional regulators of stem cells. It is of particular interest to stem cell biologists because it is linked to the self-renewal of both embryonic stem cells (ESCs) and hematopoietic stem cells (HSCs), and it is involved in human leukemia. In ESCs, the Sall4/Oct4/Nanog core transcriptional network governs the self-renewal and pluripotent properties of human and murine ESCs. In normal HSCs and leukemic stem cells (LSCs), SALL4 is linked to three known pathways that are involved in self-renewal: Wnt/β-catenin, Bmi-1, and Pten. Despite the important shared role of SALL4 in self-renewal of HSCs and LSCs, our recent studies obtained through correlating global downstream target genes and unique functional studies in normal versus leukemic cells have demonstrated that SALL4 has differential effects on both pro- and anti-apoptotic pathways in normal and leukemic cells. Targeting SALL4, particularly when combined with the use of ABT-737, a BCL2 antagonist, could lead to leukemic cell-specific apoptosis. This review summarizes our current knowledge on the SALL gene family development, particularly on the role of SALL4 in stem cells, as well as tumorigenesis, especially leukemogenesis.

REFERENZIERT VON
  1. Panis Carolina, Pizzatti Luciana, Herrera Ana Cristina, Cecchini Rubens, Abdelhay Eliana, Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution label-free proteomics, Cancer Letters, 330, 1, 2013. Crossref

  2. Gao Chong, Dimitrov Todor, Yong Kol Jia, Tatetsu Hiro, Jeong Ha-won, Luo Hongbo R., Bradner James E., Tenen Daniel G., Chai Li, Targeting transcription factor SALL4 in acute myeloid leukemia by interrupting its interaction with an epigenetic complex, Blood, 121, 8, 2013. Crossref

  3. Zhang Xu, Yuan Xiao, Zhu Wei, Qian Hui, Xu Wenrong, SALL4: An emerging cancer biomarker and target, Cancer Letters, 357, 1, 2015. Crossref

  4. Romano Maurizio, De Francesco Francesco, Gringeri Enrico, Giordano Antonio, Ferraro Giuseppe A., Di Domenico Marina, Cillo Umberto, Tumor Microenvironment Versus Cancer Stem Cells in Cholangiocarcinoma: Synergistic Effects?, Journal of Cellular Physiology, 231, 4, 2016. Crossref

  5. Quante Timo, Bird Adrian, Do short, frequent DNA sequence motifs mould the epigenome?, Nature Reviews Molecular Cell Biology, 17, 4, 2016. Crossref

  6. CHENG JI, DENG RUI, ZHANG PENG, WU CHUANQING, WU KE, SHI LIANG, LIU XINGHUA, BAI JIE, DENG MEIZHOU, SHUAI XIAOMING, GAO JINBO, WANG GUOBIN, TAO KAIXIONG, miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4, Oncology Reports, 34, 4, 2015. Crossref

  7. WANG MIN-CONG, LI CHUN-LI, CUI JIE, JIAO MIN, WU TAO, JING LI, NAN KE-JUN, BMI-1, a promising therapeutic target for human cancer, Oncology Letters, 10, 2, 2015. Crossref

  8. Bing Zhanyong, Pasha Theresa, Wang Li-Ping, Zhang Paul J., Malignant Mixed Mullerian Tumor: An Immunohistochemical Study, Pathology Research International, 2012, 2012. Crossref

  9. Liu Chuanjin, Wu Haibin, Li Yanyan, Shen Liang, Yu Renchun, Yin Hongwei, Sun Ting, Sun Chunming, Zhou Youxin, Du Ziwei, SALL4 suppresses PTEN expression to promote glioma cell proliferation via PI3K/AKT signaling pathway, Journal of Neuro-Oncology, 135, 2, 2017. Crossref

  10. Gu Mengjie, Wang Xin, Toh Tan Boon, Hooi Lissa, Tenen Daniel G., Chow Edward Kai‐Hua, Nanodiamond‐Based Platform for Intracellular‐Specific Delivery of Therapeutic Peptides against Hepatocellular Carcinoma, ADVANCED THERAPEUTICS, 1, 8, 2018. Crossref

  11. Du Wenjing, Ni Lan, Liu Baojun, Wei Ying, Lv Yubao, Qiang Sujing, Dong Jingcheng, Liu Xijun, Upregulation of SALL4 by EGFR activation regulates the stemness of CD44-positive lung cancer, Oncogenesis, 7, 4, 2018. Crossref

  12. Yang Jianchang, SALL4 as a transcriptional and epigenetic regulator in normal and leukemic hematopoiesis, Biomarker Research, 6, 1, 2018. Crossref

  13. Wu Hsing-Ju, Chu Pei-Yi, Role of Cancer Stem Cells in Cholangiocarcinoma and Therapeutic Implications, International Journal of Molecular Sciences, 20, 17, 2019. Crossref

  14. Yang Jianchang, Function of the Stem Cell Transcription Factor SALL4 in Hematopoiesis, in Transcriptional and Post-transcriptional Regulation, 2018. Crossref

  15. Farawela Hala M., Zawam Hamdy M., Al-Wakeel Hanan A., El-Nagdy Mona H., El-Refaey Fatma A., Abdel-Rahman Hala A., Expression pattern and prognostic implication of SALL4 gene in myeloid leukemias: a case-control study, Scandinavian Journal of Clinical and Laboratory Investigation, 79, 1-2, 2019. Crossref

  16. Wang Fei, Guo Ye, Chen Qian, Yang Zhuo, Ning Ning, Zhang Yujuan, Xu Yonggang, Xu Xiaodong, Tong Chunrong, Chai Li, Cui Wei, Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes, Journal of Hematology & Oncology, 6, 1, 2013. Crossref

  17. Dolfini Diletta, Minuzzo Mario, Pavesi Giulio, Mantovani Roberto, The Short Isoform of NF‐YA Belongs to the Embryonic Stem Cell Transcription Factor Circuitry, STEM CELLS, 30, 11, 2012. Crossref

  18. Liu Bee Hui, Jobichen Chacko, Chia C. S. Brian, Chan Tim Hon Man, Tang Jing Ping, Chung Theodora X. Y., Li Jia, Poulsen Anders, Hung Alvin W., Koh-Stenta Xiaoying, Tan Yaw Sing, Verma Chandra S., Tan Hong Kee, Wu Chan-Shuo, Li Feng, Hill Jeffrey, Joy Joma, Yang Henry, Chai Li, Sivaraman J., Tenen Daniel G., Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide, Proceedings of the National Academy of Sciences, 115, 30, 2018. Crossref

  19. Sun Boshu, Xu Liangliang, Bi Wenhui, Ou Wen-Bin, SALL4 Oncogenic Function in Cancers: Mechanisms and Therapeutic Relevance, International Journal of Molecular Sciences, 23, 4, 2022. Crossref

  20. Hodeib Hossam, El Amrousy Doaa, Youssef Amira, Khedr Rasha, Al-Asy Hassan, Shabana Ahmed, Elnemr Shimaa, Abdelhai Dina, Acute lymphoblastic leukemia in children and SALL4 and BMI-1 gene expression, Pediatric Research, 2021. Crossref

Digitales Portal Digitale Bibliothek eBooks Zeitschriften Referenzen und Berichte Forschungssammlungen Preise und Aborichtlinien Begell House Kontakt Language English 中文 Русский Português German French Spain